Table 3.
Blood flow velocity changes of subjects on both sides in functional outcome groups
| Total cohort (72) | mRS 0–2 (53) | mRS 3–6 (19) | p Value* | |
|---|---|---|---|---|
| Mean CBFV on ipsilateral side at baseline (cm/s) | 56.21±21.88 | 56.93±22.64 | 54.21±20.03 | 0.645 |
| Mean CBFV on ipsilateral side during ECP (cm/s) | 58.56±22.24 | 58.87±23.32 | 57.69±19.50 | 0.843 |
| CAI on ipsilateral side (%) | 4.77±5.99 | 3.71±4.94 | 7.73±7.66 | 0.044 |
| Mean CBFV on contralateral side at baseline (cm/s) | 56.16±21.31 | 54.92±19.89 | 59.64±25.12 | 0.465 |
| Mean CBFV on contralateral side during ECP (cm/s) | 58.70±22.73 | 57.11±21.10 | 63.15±26.87 | 0.324 |
| CAI on contralateral side (%) | 4.48±5.51 | 3.92±4.79 | 6.04±7.08 | 0.151 |
*Represents p values for comparison between the two groups; independent-samples Student t test was used.
Continuous data were presented as the mean±SD.
CAI, cerebral augmentation index; CBFV, cerebral blood flow velocity; ECP, external counterpulsation; mRS, modified-Rankin Scale scores.